EDARBYCLOR

This brand name is authorized in Canada, Hong Kong, United States

Active ingredients

The drug EDARBYCLOR contains a combination of these active pharmaceutical ingredients (APIs):

1 Azilsartan medoxomil UNII WEC6I2K1FC - AZILSARTAN KAMEDOXOMIL

Azilsartan medoxomil is an orally active prodrug that is rapidly converted to the active moiety, azilsartan, which selectively antagonises the effects of angiotensin II by blocking its binding to the AT1 receptor in multiple tissues. Angiotensin II is the principal pressor agent of the RAAS, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium. Read about Azilsartan medoxomil

2 Chlortalidone UNII Q0MQD1073Q - CHLORTHALIDONE

Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action. Read about Chlortalidone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EDARBYCLOR Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DA09		C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02397749, 02397765
Country: HK	Department of Health Drug Office	Identifier(s): 62249, 62250
Country: US	FDA, National Drug Code	Identifier(s): 60631-412, 60631-425